Table 5 Clinicopathological characteristics of all cases with metachronous liver metastasis.
Age | Gender | AFP* [ng/ml] | Size [mm] | pT | pN | ly | v | Histology | IHC** | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AFP | GPC3 | SALL4 | |||||||||
74 | F | 44,613 | 100 | 2 | 0 | 1 | 1 | tub2 | + | + | + |
68 | M | 254.1 | 60 | 2 | 0 | 1 | 1 | tub2 | + | + | + |
84 | M | 49.5 | 90 | 3 | 2 | 1 | 1 | tub2 | + | + | + |
68 | M | 20.7 | 53 | 1 | 0 | 1 | 2 | tub1 | + | + | + |
67 | M | 7.9 | 45 | 2 | 1 | 1 | 2 | tub1 | + | + | + |
82 | M | 3.6 | 55 | 4 | 3 | 2 | 2 | tub2 | − | − | − |
81 | M | 1.5 | 48 | 3 | 1 | 2 | 2 | tub1 | − | + | + |
77 | F | 2.5 | 30 | 3 | 0 | 3 | 3 | tub2 | − | − | − |
66 | F | 1.7 | 55 | 3 | 0 | 0 | 2 | tub1 | − | − | − |
69 | M | 4.9 | 90 | 3 | 0 | 1 | 3 | tub2 | − | − | − |
69 | M | 3.2 | 79 | 3 | 0 | 0 | 3 | tub2 | − | − | + |
73 | M | 3.1 | 50 | 3 | 1 | 1 | 3 | por1 | − | − | − |
64 | M | 3.9 | 31 | 3 | 1 | 1 | 2 | tub1 | − | − | − |
67 | M | 3.1 | 75 | 3 | 2 | 2 | 2 | tub2 | − | + | − |
52 | M | 3.4 | 32 | 3 | 3 | 3 | 2 | tub2 | − | − | − |
66 | M | 3.3 | 30 | 3 | 1 | 1 | 3 | tub2 | − | − | − |
72 | M | 1.7 | 75 | 3 | 3 | 3 | 3 | por1 | − | + | − |
78 | M | 2.1 | 25 | 1b | 0 | 0 | 0 | tub1 | − | − | − |
64 | M | 2.6 | 100 | 4b | 1 | 3 | 2 | tub2 | − | − | − |
76 | M | 1.1 | 150 | 4a | 2 | 0 | 3 | por1 | − | − | − |
73 | F | 4.7 | 40 | 4a | 3 | 2 | 2 | tub2 | − | − | − |
76 | M | 1.6 | 30 | 2 | 0 | 1c | 1c | tub2 | − | − | − |
65 | M | 5.4 | 7 | 2 | 3a | 1 | 3 | por1 | − | + | − |
86 | M | 3.2 | 51 | 1a | 0 | 0 | 0 | tub1 | − | − | − |
